Therapeutics
In this section you will find Therapeutics market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Triple Analysis: Leukemia, Angiogenesis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Prostate Cancer and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Lung Cancer, Lymphoma and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Colorectal Cancer and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Melanoma, Pancreatic Cancer and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Pancreatic Cancer, Apoptosis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Apoptosis, Cancer Vaccines and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies by mechanism/target/effect of Apoptosis, Cancer Vaccines and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Protein Kinase Inhibitors and by the two compound strategies of Antibodies and Peptides. Learn More -
Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Colorectal Cancer, Lymphoma and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Lymphoma, Apoptosis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Melanoma, Angiogenesis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Prostate Cancer, Apoptosis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More
Therapeutics
In this section you will find Therapeutics market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Triple Analysis: Leukemia, Angiogenesis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Prostate Cancer and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Lung Cancer, Lymphoma and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Colorectal Cancer and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Melanoma, Pancreatic Cancer and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Pancreatic Cancer, Apoptosis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Apoptosis, Cancer Vaccines and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies by mechanism/target/effect of Apoptosis, Cancer Vaccines and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Protein Kinase Inhibitors and by the two compound strategies of Antibodies and Peptides. Learn More -
Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Colorectal Cancer, Lymphoma and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Lymphoma, Apoptosis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Melanoma, Angiogenesis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Prostate Cancer, Apoptosis and Protein Kinase Inhibitors
$4,495.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More